NCT04745780View on ClinicalTrials.gov

Evaluation of Efficacy and Safety of a Combination Containing Myo-inositol, D-chiro-inositol, Alpha-lactalbumin, Zinc and Extract of Gymnema Sylvestre in Subjects Diabetic Patients.

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 10, 2021

Primary Completion Date

September 30, 2022

Study Completion Date

December 22, 2022

Conditions

Type 2 Diabetes

Interventions

DIETARY_SUPPLEMENT

Myo-inositol, D-chiro-inositol, Gymnema sylvestre, Zinc and Alpha-lactalbumin

Myo-inositol (1950 mg), D-chiro-inositol (50 mg), Gymnema sylvestre (250 mg), Zinc (7,5 mg) and Alpha-lactalbumin (50 mg) - Two-times daily on an empty stomach, for 6 months

DIETARY_SUPPLEMENT

Placebo

Placebo - Two-times daily on an empty stomach, for 6 months

Trial Locations (1)

20162

Basilio Pintaudi, Milan